Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 68NETWORK 23NIH 18INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 12Other hematologic neoplasm 11Breast 11Classical hematology 4Thoracic 3Plasma cell 3Other solid neoplasm 3Myeloid 3Sarcoma 2Gastrointestinal 2Dermatologic 1CNS 1

Conditions

Sarcoma 1Recurrence 1Optic Nerve Glioma 1Oligodendroglioma 1Neutropenia 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Bone Neoplasms 1Astrocytoma 1

Interventions

Doxorubicin 44Imatinib Mesylate 33pembrolizumab 23Cyclophosphamide 23Sunitinib 22Gemcitabine 22Temozolomide 17Irinotecan 14Bevacizumab 14Docetaxel 13nilotinib 12Trabectedin 12ripretinib 11pazopanib 11olaratumab 10fludarabine 10eribulin 10regorafenib 9avapritinib 9Fluorouracil 9Carboplatin 9Paclitaxel 8Nivolumab 8Ifosfamide 8Ibandronic Acid 8spartalizumab 7anlotinib 7Vincristine 7Radiation 7Ipilimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Filgrastim × Sarcoma × Clear all
NCT00004212 2012-05-16

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Daiichi Sankyo

Phase 1 Completed
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Oligodendroglioma, Recurrence, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

NCT00035620 2010-02-26

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Amgen

Phase 2 Completed
44 enrolled
Sarcoma

Bone Neoplasms, Neutropenia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡